{"id":"https://openalex.org/W4412079674","doi":"https://doi.org/10.1016/j.biopsych.2025.07.004","title":"Mu Opioid Receptor Activation Is Required for NMDA Receptor Antagonist Effects on Stress-Induced Maladaptive Behavior","display_name":"Mu Opioid Receptor Activation Is Required for NMDA Receptor Antagonist Effects on Stress-Induced Maladaptive Behavior","publication_year":2025,"publication_date":"2025-07-07","ids":{"openalex":"https://openalex.org/W4412079674","doi":"https://doi.org/10.1016/j.biopsych.2025.07.004","pmid":"https://pubmed.ncbi.nlm.nih.gov/40633884"},"language":"en","primary_location":{"id":"doi:10.1016/j.biopsych.2025.07.004","doi":"https://doi.org/10.1016/j.biopsych.2025.07.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopsych.2025.07.004","pdf_url":"https://www.biologicalpsychiatryjournal.com/article/S0006-3223(25)01311-3/pdf","source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.biologicalpsychiatryjournal.com/article/S0006-3223(25)01311-3/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075946728","display_name":"Cory B. Langreck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4210147620","display_name":"Research Foundation For Mental Hygiene","ror":"https://ror.org/042ckra75","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147620"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cory B. Langreck","raw_affiliation_strings":["Doctoral Program in Pharmacology and Molecular Signaling, Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York; Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc., New York State Psychiatric Institute, New York, New York; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York","Doctoral Program in Pharmacology and Molecular Signaling, Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Doctoral Program in Pharmacology and Molecular Signaling, Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York; Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc., New York State Psychiatric Institute, New York, New York; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]},{"raw_affiliation_string":"Doctoral Program in Pharmacology and Molecular Signaling, Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057150314","display_name":"Briana K. Chen","orcid":"https://orcid.org/0000-0003-1982-1389","observed_orcids":["https://orcid.org/0000-0003-1982-1389"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4210147620","display_name":"Research Foundation For Mental Hygiene","ror":"https://ror.org/042ckra75","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147620"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Briana K. Chen","raw_affiliation_strings":["Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York","Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]},{"raw_affiliation_string":"Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061769906","display_name":"Victor M. Luna","orcid":"https://orcid.org/0000-0002-6879-4308","observed_orcids":["https://orcid.org/0000-0002-6879-4308"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor M. Luna","raw_affiliation_strings":["Alzheimer's Center at Temple, Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania","Alzheimer's Center at Temple, Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer's Center at Temple, Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I84392919"]},{"raw_affiliation_string":"Alzheimer's Center at Temple, Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103989453","display_name":"Mel Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4210147620","display_name":"Research Foundation For Mental Hygiene","ror":"https://ror.org/042ckra75","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147620"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mel Nelson","raw_affiliation_strings":["Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc., New York State Psychiatric Institute, New York, New York; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York","Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc., New York State Psychiatric Institute, New York, New York; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]},{"raw_affiliation_string":"Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063541987","display_name":"Gergely F. Turi","orcid":"https://orcid.org/0000-0001-5651-9459","observed_orcids":["https://orcid.org/0000-0001-5651-9459"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4210147620","display_name":"Research Foundation For Mental Hygiene","ror":"https://ror.org/042ckra75","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147620"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gergely Turi","raw_affiliation_strings":["Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York","Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]},{"raw_affiliation_string":"Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rob Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rob Hill","raw_affiliation_strings":["Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, United Kingdom","Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, United Kingdom","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]},{"raw_affiliation_string":"Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, UK","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061779058","display_name":"Gilles Rubinstenn","orcid":"https://orcid.org/0009-0008-9762-8932","observed_orcids":["https://orcid.org/0009-0008-9762-8932"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gilles Rubinstenn","raw_affiliation_strings":["ReST Therapeutics, Paris, France","ReST Therapeutics, Paris, 75006, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ReST Therapeutics, Paris, France","institution_ids":[]},{"raw_affiliation_string":"ReST Therapeutics, Paris, 75006, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045741606","display_name":"Meritxell Canals","orcid":"https://orcid.org/0000-0002-7942-5006","observed_orcids":["https://orcid.org/0000-0002-7942-5006"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Meritxell Canals","raw_affiliation_strings":["Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, United Kingdom","Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, United Kingdom","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]},{"raw_affiliation_string":"Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, UK","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022343281","display_name":"J. Robert Lane","orcid":"https://orcid.org/0000-0002-7361-7875","observed_orcids":["https://orcid.org/0000-0002-7361-7875"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Robert Lane","raw_affiliation_strings":["Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, United Kingdom","Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, United Kingdom","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]},{"raw_affiliation_string":"Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Centre of Membrane Proteins and Receptors, Universities of Nottingham and Birmingham, Midlands, UK","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027515817","display_name":"Christine Ann Denny","orcid":"https://orcid.org/0000-0002-6926-2020","observed_orcids":["https://orcid.org/0000-0002-6926-2020"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4210147620","display_name":"Research Foundation For Mental Hygiene","ror":"https://ror.org/042ckra75","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147620"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christine A. Denny","raw_affiliation_strings":["Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York. Electronic address: cad2125@cumc.columbia.edu","Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA. Electronic address: cad2125@cumc.columbia.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York. Electronic address: cad2125@cumc.columbia.edu","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]},{"raw_affiliation_string":"Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA. Electronic address: cad2125@cumc.columbia.edu","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076865147","display_name":"Jonathan A. Javitch","orcid":"https://orcid.org/0000-0001-7395-2967","observed_orcids":["https://orcid.org/0000-0001-7395-2967"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4210147620","display_name":"Research Foundation For Mental Hygiene","ror":"https://ror.org/042ckra75","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147620"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonathan A. Javitch","raw_affiliation_strings":["Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc., New York State Psychiatric Institute, New York, New York; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York. Electronic address: jaj2@cumc.columbia.edu","Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA. Electronic address: jaj2@cumc.columbia.edu"],"raw_orcid":"https://orcid.org/0000-0001-7395-2967","affiliations":[{"raw_affiliation_string":"Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc., New York State Psychiatric Institute, New York, New York; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York. Electronic address: jaj2@cumc.columbia.edu","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]},{"raw_affiliation_string":"Division of Molecular Therapeutics, Research Foundation for Mental Hygiene, Inc. (RFMH) / New York State Psychiatric Institute (NYSPI), New York, NY 10032, USA; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA; Department of Psychiatry, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA. Electronic address: jaj2@cumc.columbia.edu","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5027515817","https://openalex.org/A5076865147"],"corresponding_institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210147620","https://openalex.org/I4388891851"],"apc_list":{"value":5489,"currency":"USD","value_usd":5489},"apc_paid":{"value":5489,"currency":"USD","value_usd":5489},"fwci":4.8333,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.96326442,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"99","issue":"4","first_page":"299","last_page":"310"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8199999928474426},{"id":"https://openalex.org/keywords/behavioral-despair","display_name":"behavioral despair","score":0.921999990940094},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.6000000238418579},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.9190000295639038},{"id":"https://openalex.org/keywords/ketamine-enantiomers","display_name":"ketamine enantiomers","score":0.75}],"concepts":[{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6628268957138062},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.6059472560882568},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5731990337371826},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5116972923278809},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4553431272506714},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42489710450172424},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.42190277576446533},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3653299808502197},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28183549642562866},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21381786465644836}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013315","descriptor_name":"Stress, Psychological","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D013315","descriptor_name":"Stress, Psychological","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.biopsych.2025.07.004","doi":"https://doi.org/10.1016/j.biopsych.2025.07.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopsych.2025.07.004","pdf_url":"https://www.biologicalpsychiatryjournal.com/article/S0006-3223(25)01311-3/pdf","source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},{"id":"pmid:40633884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40633884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological psychiatry","raw_type":"Journal Article"},{"id":"pmh:oai:https://nottingham-repository.worktribe.com/:51613338","doi":null,"is_oa":true,"landing_page_url":"https://nottingham-repository.worktribe.com/output/51613338","pdf_url":"https://nottingham-repository.worktribe.com/preview/51613363/PIIS0006322325013113.pdf","source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.biopsych.2025.07.004","doi":"https://doi.org/10.1016/j.biopsych.2025.07.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopsych.2025.07.004","pdf_url":"https://www.biologicalpsychiatryjournal.com/article/S0006-3223(25)01311-3/pdf","source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309008","display_name":"Hope for Depression Research Foundation","ror":"https://ror.org/01mcwn339"},{"id":"https://openalex.org/F4320320241","display_name":"Academy of Medical Sciences","ror":"https://ror.org/00c489v88"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412079674.pdf","grobid_xml":"https://content.openalex.org/works/W4412079674.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W72199885","https://openalex.org/W254805310","https://openalex.org/W1586476523","https://openalex.org/W1953082779","https://openalex.org/W1982874357","https://openalex.org/W1989163516","https://openalex.org/W2023081218","https://openalex.org/W2023307247","https://openalex.org/W2033525233","https://openalex.org/W2033919519","https://openalex.org/W2035312998","https://openalex.org/W2040159169","https://openalex.org/W2040476888","https://openalex.org/W2047804695","https://openalex.org/W2060234052","https://openalex.org/W2069696287","https://openalex.org/W2076244291","https://openalex.org/W2111728433","https://openalex.org/W2164953364","https://openalex.org/W2170790660","https://openalex.org/W2172323892","https://openalex.org/W2204218248","https://openalex.org/W2346390990","https://openalex.org/W2581467609","https://openalex.org/W2779386549","https://openalex.org/W2785770559","https://openalex.org/W2791285903","https://openalex.org/W2791680789","https://openalex.org/W2811304329","https://openalex.org/W2886819021","https://openalex.org/W2889166554","https://openalex.org/W2904749524","https://openalex.org/W2910925824","https://openalex.org/W2920714184","https://openalex.org/W2946661342","https://openalex.org/W2959913173","https://openalex.org/W2969864748","https://openalex.org/W2980021052","https://openalex.org/W3000480376","https://openalex.org/W3025572281","https://openalex.org/W3042772214","https://openalex.org/W3131964300","https://openalex.org/W3156594315","https://openalex.org/W3161528957","https://openalex.org/W3178497840","https://openalex.org/W3197053538","https://openalex.org/W4200437000","https://openalex.org/W4220994164","https://openalex.org/W4238102997","https://openalex.org/W4312204714","https://openalex.org/W4328051515","https://openalex.org/W4384028768","https://openalex.org/W4387763730","https://openalex.org/W4391350368","https://openalex.org/W4391738621","https://openalex.org/W4406065584","https://openalex.org/W4406381233","https://openalex.org/W4409596924"],"related_works":["https://openalex.org/W4410083984","https://openalex.org/W4224243283","https://openalex.org/W3161528957","https://openalex.org/W3027566423","https://openalex.org/W3027868414","https://openalex.org/W7138941105","https://openalex.org/W2765759410","https://openalex.org/W4392520252","https://openalex.org/W4313200622","https://openalex.org/W4312204714"],"abstract_inverted_index":{"BACKGROUND:":[0],"Contradictory":[1],"evidence":[2],"has":[3],"emerged":[4],"regarding":[5],"the":[6,9,15,24,32,37,42,95,121,165,191],"role":[7],"of":[8,18,34,39,97,118,125,132,147,167,193,211],"mu":[10],"opioid":[11,216],"receptor":[12,46],"(MOR)":[13],"in":[14,70,79,179],"antidepressant":[16],"actions":[17,38],"(R,S)-ketamine.":[19],"METHODS:":[20],"Here,":[21],"we":[22],"used":[23,92],"long-acting":[25],"MOR-selective":[26],"antagonist":[27,48],"methocinnamox":[28],"(MCAM)":[29],"to":[30,36,66,93,141],"determine":[31,94],"contribution":[33],"MOR":[35,69,98,181,186],"(R,S)-ketamine":[40,55,74,107,110,133,157,195],"and":[41,57,59,75,111,123,138,158,183,196],"more":[43,136,139],"selective":[44],"NMDA":[45],"(NMDAR)":[47],"fluoroethylnormemantine":[49],"(FENM)":[50],"against":[51,198],"stress-induced":[52,199],"maladaptive":[53,200],"behaviors.":[54],"enantiomers":[56,113],"metabolites":[58],"FENM":[60,76,126,159,197],"were":[61,77,127],"assessed":[62],"for":[63,190],"their":[64,177],"ability":[65],"directly":[67],"activate":[68],"cell":[71],"signaling":[72],"assays.":[73],"tested":[78],"various":[80],"behavioral":[81,161],"paradigms":[82],"with":[83],"vehicle":[84],"or":[85,153,173],"MCAM":[86,144,163],"pretreatment.":[87],"Patch":[88],"clamp":[89],"electrophysiology":[90],"was":[91,134],"effects":[96,166],"antagonism":[99,213],"on":[100,214],"ventral":[101],"hippocampal":[102],"CA3":[103],"glutamatergic":[104],"activity":[105,182],"after":[106,154,174],"administration.":[108],"RESULTS:":[109],"its":[112],"showed":[114],"weak":[115],"partial":[116],"agonism":[117],"MOR,":[119],"whereas":[120],"potency":[122],"efficacy":[124,192],"negligible.":[128],"The":[129],"antinociceptive":[130],"effect":[131,210],"both":[135,156,168,194],"potent":[137],"sensitive":[140],"blockade":[142],"by":[143],"than":[145],"that":[146,203],"FENM.":[148],"When":[149],"given":[150,171],"either":[151],"before":[152,172],"stress,":[155,175],"reduced":[160],"despair.":[162],"prevented":[164],"NMDAR":[169,212],"antagonists":[170],"despite":[176],"differences":[178],"direct":[180],"antinociception.":[184],"CONCLUSIONS:":[185],"activation":[187],"is":[188],"required":[189],"behavior,":[201],"suggesting":[202],"these":[204],"compounds":[205],"function":[206],"through":[207],"an":[208],"indirect":[209],"endogenous":[215],"signaling.":[217]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2025-10-10T00:00:00"}